HVC

Healthcare Value Capital Portfolio holdings

AUM $38.5M
This Quarter Return
-0.31%
1 Year Return
+22.29%
3 Year Return
+31.09%
5 Year Return
+125.72%
10 Year Return
–
AUM
$43.1M
AUM Growth
+$43.1M
Cap. Flow
-$13.8M
Cap. Flow %
-31.99%
Top 10 Hldgs %
99.12%
Holding
21
New
1
Increased
–
Reduced
1
Closed
3

Top Buys

1
LAB icon
Standard BioTools
LAB
$1.57M

Top Sells

1
ANIP icon
ANI Pharmaceuticals
ANIP
$9.09M
2
AMGN icon
Amgen
AMGN
$3.66M
3
ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
$2.54M
4
FCSC
Fibrocell Science Inc.
FCSC
$64K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NVLN
1
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$8.93M 15.27% 831,440 – –
PFE icon
2
Pfizer
PFE
$141B
$8.55M 14.63% 250,000 – –
GILD icon
3
Gilead Sciences
GILD
$140B
$5.09M 8.71% 75,000 – –
ASRT icon
4
Assertio
ASRT
$80.4M
$4.39M 7.51% 350,000 – –
AMRI
5
DELISTED
Albany Molecular Research Inc
AMRI
$4.24M 7.26% 302,400 – –
AGN
6
DELISTED
Allergan plc
AGN
$3.58M 6.13% 15,000 – –
AORT icon
7
Artivion
AORT
$2.07B
$2.5M 4.27% 150,000 – –
TEVA icon
8
Teva Pharmaceuticals
TEVA
$21.1B
$2.41M 4.12% 75,000 – –
LAB icon
9
Standard BioTools
LAB
$481M
$1.57M 2.68% +275,000 New +$1.57M
AMRN
10
Amarin Corp
AMRN
$311M
$1.44M 2.46% 450,000 – –
ZGNX
11
DELISTED
Zogenix, Inc.
ZGNX
$346K 0.59% 31,850 – –
FCSC
12
DELISTED
Fibrocell Science Inc.
FCSC
$32K 0.05% 15,923 -31,846 -67% -$64K
AMGN icon
13
Amgen
AMGN
$155B
– – -25,000 Closed -$3.66M
ANIP icon
14
ANI Pharmaceuticals
ANIP
$2.03B
– – -150,000 Closed -$9.09M
BIS icon
15
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.47M
– – 0 – –
SPY icon
16
SPDR S&P 500 ETF Trust
SPY
$658B
– – 0 – –
VIXY icon
17
ProShares VIX Short-Term Futures ETF
VIXY
$87.1M
– – 0 – –
VIRX
18
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– – 0 – –
IMMU
19
DELISTED
Immunomedics Inc
IMMU
– – 0 – –
IPXL
20
DELISTED
Impax Laboratories, Inc.
IPXL
– – 0 – –
ARLZ
21
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
– – -575,000 Closed -$2.54M